HeartSciences annual r&d spending
2022
2023
2024
2025
2026
HeartSciences R&D Spending Growth & History (HSCS)
HeartSciences's r&d spending was $2.8M for fiscal 2026.
View full HeartSciences company overviewHeartSciences annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-04-30 | $2.8M | −$1.5M | −35.27% |
| 2025 | 2025-04-30 | $4.4M | $1.5M | +52.37% |
| 2024 | 2024-04-30 | $2.9M | $417,686 | +16.97% |
| 2023 | 2023-04-30 | $2.5M | −$540,664 | −18.01% |
| 2022 | 2022-04-30 | $3.0M | — | — |
HeartSciences quarterly r&d spending
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-04-30 | $476,205 | −$452,886 | −48.75% |
| Q3 2026 | 2026-01-31 | $638,575 | −$394,543 | −38.19% |
| Q2 2026 | 2025-10-31 | $727,026 | −$471,939 | −39.36% |
| Q1 2026 | 2025-07-31 | $997,206 | −$227,725 | −18.59% |
| Q4 2025 | 2025-04-30 | $929,091 | −$117,021 | −11.19% |
| Q3 2025 | 2025-01-31 | $1.0M | $523,611 | +102.77% |
| Q2 2025 | 2024-10-31 | $1.2M | $441,662 | +58.32% |
| Q1 2025 | 2024-07-31 | $1.2M | $659,299 | +116.56% |
| Q4 2024 | 2024-04-30 | $1.0M | $511,676 | +95.74% |
| Q3 2024 | 2024-01-31 | $509,507 | −$133,751 | −20.79% |
| Q2 2024 | 2023-10-31 | $757,303 | −$91,673 | −10.80% |
| Q1 2024 | 2023-07-31 | $565,632 | $131,434 | +30.27% |
| Q4 2023 | 2023-04-30 | $534,436 | −$821,194 | −60.58% |
| Q3 2023 | 2023-01-31 | $643,258 | −$55,757 | −7.98% |
| Q2 2023 | 2022-10-31 | $848,976 | $303,203 | +55.55% |
| Q1 2023 | 2022-07-31 | $434,198 | $33,084 | +8.25% |
| Q4 2022 | 2022-04-30 | $1.4M | — | — |
| Q3 2022 | 2022-01-31 | $699,015 | — | — |
| Q2 2022 | 2021-10-31 | $545,773 | — | — |
| Q1 2022 | 2021-07-31 | $401,114 | — | — |
HeartSciences r&d spending trends
Between the periods ended 2022-04-30 and 2026-04-30, HeartSciences's r&d spending decreased from $3.0M to $2.8M, a change of −$162,520. The latest reported quarter, Q4 2026, shows $476,205.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HeartSciences source filings ↗